Kathy Pritchard-Jones – President, International Society of…
Kathy Pritchard-Jones, Professor of Paediatric Oncology at University College London (UCL) and President of the International Society of Paediatric…
Zack Pemberton-Whiteley – CEO, Leukaemia Care
Zack Pemberton-Whiteley, CEO of UK-based blood cancer charity Leukaemia Care, discusses the importance of patient and patient organizations’…
Janet Downie – CEO, Roslin CT, UK
A spinout from the Roslin Institute that created Dolly the Sheep, Roslin CT is a cell and gene therapy CDMO, with a unique positioning in the field…
Jonny Ohlson – CEO, Touchlight, UK
Jonny Ohlson, founder & CEO of Touchlight, discusses the genetic medicine revolution and the role of Touchlight in disrupting the field with its…
Geoffrey Guy, Chairman, GW Pharma
Dr. Geoffrey Guy, chairman and founder of cannabinoid medicine pioneer, GW Pharma, outlines the potential benefits that Brexit could bring to the…
Kevin Cook – CEO, Sterling Pharma Solutions, UK
Sterling Pharma Solutions is a rapidly growing GMP contract API manufacturer based out of Dudley, Cramlington in the Northeast of England. The company…
David Atkins – CEO, Congenica, UK
Offering genomic sequencing and analysis, Congenica operates in the exciting world of genomic diagnosis, with a particular focus on rare diseases. Its…
Sean Richardson – GM, Alexion Pharma UK
Sean Richardson discusses Alexion’s focus on rare and ultra-rare diseases, the level of support for these therapies from the UK government,…
Angela McFarlane – Market Development Director, IQVIA UK
With over 30 years of experience in the life sciences industry, Angela McFarlane explains why the UK will not be removed from its position in the top…
Ewan McDowall – GM, Ipsen UK and Ireland (July 2014 –…
For Ipsen, the UK is one of three global hubs, with manufacturing in Wales in which it is continuously investing, as well as large-scale R&D…
David Garway-Heath – Moorfields Eye Hospital, UK
Professor David Garway-Heath, a specialist in glaucoma, talks with us about the screening devices of the future, low awareness of glaucoma as a…
Karen Osborn – CEO, International Glaucoma Association, UK
Karen Osborn, CEO of the International Glaucoma Association, explains the role of the charity, detailing its threefold purpose of funding research,…